Fundraising Fox
Unobio
1 known investors
Find your way into Unobio
Sign up to see every warm intro you have to Unobio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Unobio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.
Investors · 1
Related companies · 3
AviadoBioAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Companies working in the same space as Unobio.
Frequently asked questions
- What does Unobio do?
- Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.
- Who are Unobio's investors?
- Unobio's investors include Focal Ventures.